
Enochian Biosciences' CEO Letter to Shareholders
(ENOB) -- Accelerated Pre-Investigational New Drug (Pre-IND) submission to the US Food and Drug Administration (FDA) for potential cancer product due to additional promising results from...
(ENOB) -- Accelerated Pre-Investigational New Drug (Pre-IND) submission to the US Food and Drug Administration (FDA) for potential cancer product due to additional promising results from...
(ENOB). Enochian BioSciences Inc. (the Company) announced that it has achieved full compliance with NASDAQ filing requirements. The Annual Report on Form 10-K was filed on February 27, 2023,...
(ENOB) -- On February 16, 2023, Enochian BioSciences Inc. (the "Company") received a notice (the "Notice") from The Nasdaq Stock Market LLC ("Nasdaq") stating that because the Company has...
Investing.com – U.S. equities were lower at the close on Monday, as losses in the Consumer Services, Technology and Basic Materials sectors propelled shares lower. At the close in NYSE, the...
Investing.com – U.S. equities were higher at the close on Wednesday, as gains in the Consumer Services, Oil & Gas and Consumer Goods sectors propelled shares higher. At the close in NYSE,...
By Dhirendra Tripathi Investing.com – Enochian Biosciences (NASDAQ:ENOB) stock rose more than 5% in Monday’s premarket but was trading up 0.4% early in the official trading session after the...
Investing.com – U.S. equities were mixed at the close on Monday, as gains in the Technology, Consumer Services and Utilities sectors propelled shares higher while losses in the Basic...
Investing.com – U.S. equities were lower at the close on Tuesday, as losses in the Financials, Industrials and Oil & Gas sectors propelled shares lower. At the close in NYSE, the Dow Jones...
Investing.com – U.S. equities were higher at the close on Monday, as gains in the Technology, Healthcare and Consumer Services sectors propelled shares higher. At the close in NYSE, the Dow...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.